Sign in

CIK 0001799448 · Non-accelerated filer<br>Smaller reporting company

Aligos Therapeutics, Inc.

Sign in to watch
Ticker
ALGS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
(800) 466-6059
Business address
ONE CORPORATE DR., 2ND FLOOR, SOUTH SAN FRANCISCO, CA, 94080
  1. 8-K Event Results of operations
  2. SC 13D/A Stake Beneficial Ownership Report
  3. 4 Other disposition Director disposed of 504,084 shares (other)
  4. 4 Derivatives Options or other derivatives
  5. 3 Insider Initial Statement of Ownership
  6. DEFA14A Proxy Proxy Materials
  7. DEF 14A Proxy Proxy Statement
  8. 8-K Event Executive or director change
  9. S-8 Other Securities Offered to Employees in Benefit Plans
  10. 10-K Report Annual Report
  11. 8-K Event Results of operations
  12. SC 13G Stake Amended Statement of Ownership
  13. SC 13G Stake Amended Statement of Ownership
  14. SC 13G Stake Amended Statement of Ownership
  15. SC 13G Stake Amended Statement of Ownership
  16. SC 13G Stake Amended Statement of Ownership
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 15 of 18 · 348 filings